| Looking Back at Recent Earnings from Nektar Therapeutics; NKTR, HSP, ALKS, PETS |
Learning Markets
Hospira Inc. (HSP) [Chart - Analysis - News] is the largest company in the Drug Delivery industry (based on market cap), and has been doing well recently. ...
|
| Halcygen positive about 2011 |
Sydney Morning Herald
Halcygen, which acquired Mayne Pharma International Pty Ltd from Hospira Inc in November 2009, on Tuesday reported a net profit of $3.25 million for the ...
|
| Hospira near Key Resistance Area |
TradersHuddle.com
New York, August 30th (TradersHuddle.com) - Shares of Hospira, Inc. (NYSE:HSP) are trading very close to calculated resistance at $53.61 with the current ...
|
| People on the move: pharma jobs |
In-PharmaTechnologist.com
Christopher Begley is to step down as CEO of Hospira after six years in the position. Begley will continue as CEO until Hospira has named his successor. ...
|
| Court Report |
Patent Docs (blog)
... 2009) and 7598343 (same title, issued October 6, 2009) following a Paragraph IV certification as part of Hospira's filing of an ANDA to manufacture a ...
|
| Lowest Sales Growth in the Health Care Equipment Industry Detected in Shares ... |
Comtex Smartrend
Hospira (NYSE:HSP) had sales growth of 1.2% during the last fiscal year. The company has reported $4 billion in sales over the past 12 months and is ...
|
| Anesthesia shortage may delay executions |
USA Today
Hospira, based outside Chicago, the sole US manufacturer of sodium thiopental, says manufacturing problems have hindered production of the drug, ...
|
